Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Mycobacterium tuberculosis 11 kDa allergen vs TB-PPD for TB diagnosis
CTR20140003Phase 3Active
- Sponsor
- Beijing Simcere Sanroad Biological Products
- Start
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant mycobacterium tuberculosis 11-kDa allergen in Tuberculosis (TB), sponsored by Beijing Simcere Sanroad Biological Products. Started Jun 2014; status: active.
02
Drugs
recombinant mycobacterium tuberculosis 11-kDa allergen
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on CTR20140003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140003.